Diabetes Care Devices Market by Product (Blood Glucose Monitoring Devices and Insulin Delivery Devices) - Global Opportunity Analysis and Industry Forecasts, 2017-2023
- ALL1558760
- 120 Pages
- August 2017
- Healthcare
The global diabetes care devices market was valued at $6,867 million in 2016, and is growing at a CAGR of 5.8% from 2017 to 2023 to reach $10,208 million by 2023. Diabetes care devices are used to check the blood glucose or the insulin level in a patient’s body.
The major factor that contributes to the growth of the diabetes care devices market include the increase in incidence rate of diabetes caused by rapid urbanization and sedentary lifestyle. Moreover, technological advancements in the field of diabetes devices, rise in obese population, consumption of junk food, and surge in need for faster and safer diagnosis and treatment of diabetes further boosts the market growth. However, blood glucose monitoring devices do not measure the exact level of glucose in blood and give a range in which the blood glucose level of a patient may lie. In addition, adverse effects associated with some of the diabetes care devices also hinder the market growth. In addition, rise in awareness about diabetes monitoring devices, and untapped market opportunities in the developing regions are expected to provide numerous opportunities for the market growth.
Diabetes care devices market is segmented on the basis of type and region. Based on type, the market is bifurcated into blood glucose monitoring devices and insulin delivery devices. Blood glucose monitoring devices are categorized into testing strips, self-monitoring blood glucose meters, lancets, and continuous glucose monitoring devices. Insulin delivery devices segment is further divided into insulin syringes, insulin pens, insulin pumps, and insulin jet injectors. By geography, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
- The report provides information about the current and upcoming trends in the market from 2016 to 2023, which helps to determine the prevailing opportunities.
- Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
- Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale are provided.
- Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which help understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
BY PRODUCT
- Blood Glucose Monitoring Devices
- Testing Strips
- Self-monitoring Blood Glucose Meters
- Lancets
- Continuous Blood Glucose Monitoring Devices
- Insulin Delivery Devices
- Insulin Syringes
- Insulin Pens
- Insulin Pumps
- Insulin Jet Injectors
BY REGION
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
- Abbott Laboratories
- ACON Laboratories, Inc.
- Ascensia Diabetes Care Holdings AG (formerly diabetes case business of Bayer AG)
- Becton, Dickinson and Company
- Dexcom, Inc.
- F. Hoffmann-La Roche Ltd
- Johnson & Johnson
- Medtronic plc
- Novo Nordisk A/S
- Terumo Corporation
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
- Arkray, Inc.
- Echo Therapeutics, Inc.
- Glysens Incorporated
- Insulet Corporation
- Sanofi
- Ypsomed AG
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.2.1. Competitive intelligence of companies and their strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.4.4. Impact analysis
3.5. CLINICAL TRIALS
CHAPTER 4 GLOBAL DIABETES CARE DEVICES MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. BLOOD GLUCOSE MONITORING DEVICES
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Testing Strips
4.2.4.1. Market size and forecast
4.2.5. Self-monitoring Blood Glucose Meters
4.2.5.1. Market size and forecast
4.2.6. Lancets
4.2.6.1. Market size and forecast
4.2.7. Continuous Glucose Monitors
4.2.7.1. Market size and forecast
4.3. INSULIN DELIVERY DEVICES
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Insulin Syringes
4.3.4.1. Market size and forecast
4.3.5. Insulin Pens
4.3.5.1. Market size and forecast
4.3.6. Insulin Pumps
4.3.6.1. Market size and forecast
4.3.7. Insulin Jet Injectors
4.3.7.1. Market size and forecast
CHAPTER 5 DIABETES CARE DEVICES MARKET, BY REGION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. NORTH AMERICA
5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.2.4. U.S.
5.2.5. Canada
5.2.6. Mexico
5.3. EUROPE
5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
5.3.4. Germany
5.3.5. France
5.3.6. UK
5.3.7. Italy
5.3.8. Spain
5.3.9. Rest of Europe
5.4. ASIA-PACIFIC
5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast
5.4.4. Japan
5.4.5. China
5.4.6. India
5.4.7. Australia
5.4.8. South Korea
5.4.9. Rest of Asia-Pacific
5.5. LAMEA
5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast
5.5.4. Brazil
5.5.5. South Africa
5.5.6. Saudi Arabia
5.5.7. Rest of LAMEA
CHAPTER 6 COMPANY PROFILES
6.1. ABBOTT LABORATORIES
6.1.1. Company overview
6.1.2. Operating business segments
6.1.3. Business performance
6.1.4. Key strategic moves and developments
6.2. ACON LABORATORIES, INC.
6.2.1. Company overview
6.2.2. Operating business segments
6.2.3. Business performance
6.2.4. Key strategic moves and developments
6.3. ASCENSIA DIABETES CARE HOLDINGS AG
6.3.1. Company overview
6.3.2. Operating business segments
6.3.3. Key strategic moves and developments
6.4. BECTON, DICKINSON AND COMPANY
6.4.1. Company overview
6.4.2. Operating business segments
6.4.3. Business performance
6.4.4. Key strategic moves and developments
6.5. DEXCOM, INC.
6.5.1. Company overview
6.5.2. Operating business segments
6.5.3. Business performance
6.5.4. Key strategic moves and developments
6.6. F. HOFFMANN-LA ROCHE LTD.
6.6.1. Company overview
6.6.2. Operating business segments
6.6.3. Business performance
6.6.4. Key strategic moves and developments
6.7. JOHNSON & JOHNSON
6.7.1. Company overview
6.7.2. Operating business segments
6.7.3. Business performance
6.7.4. Key strategic moves and developments
6.8. MEDTRONIC PLC
6.8.1. Company overview
6.8.2. Operating business segments
6.8.3. Business performance
6.8.4. Key strategic moves and developments
6.9. NOVO NORDISK A/S
6.9.1. Company overview
6.9.2. Operating business segments
6.9.3. Business performance
6.9.4. Key strategic moves and developments
6.10. TERUMO CORPORATION
6.10.1. Company overview
6.10.2. Operating business segments
6.10.3. Business performance
6.10.4. Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL DIABETES CARE DEVICES MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 2. BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 3. BLOOD GLUCOSE MONITORING DEVICES MARKET, BY REGION, 2016-2023, ($MILLION)
TABLE 4. BLOOD GLUCOSE MONITORING DEVICES, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 5. INSULIN DELIVERY DEVICES, BY TYPE, 2016-2023, ($MILLION)
TABLE 6. INSULIN DELIVERY DEVICES, BY REGION, 2016-2023, ($MILLION)
TABLE 7. INSULIN DELIVERY DEVICES, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 8. DIABETES CARE DEVICES MARKET, BY REGION, 2016-2023, ($MILLION)
TABLE 9. NORTH AMERICA DIABETES CARE DEVICES MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 10. NORTH AMERICA DIABETES CARE DEVICES MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 11. U.S. DIABETES CARE DEVICES MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 12. CANADA DIABETES CARE DEVICES MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 13. MEXICO DIABETES CARE DEVICES MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 14. EUROPE DIABETES CARE DEVICES MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 15. EUROPE PTCA BALLOON CATHETERS MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 16. GERMANY DIABETES CARE DEVICES MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 17. FRANCE DIABETES CARE DEVICES MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 18. UK DIABETES CARE DEVICES MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 19. ITALY DIABETES CARE DEVICES MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 20. SPAIN DIABETES CARE DEVICES MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 21. REST OF EUROPE DIABETES CARE DEVICES MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 22. ASIA-PACIFIC DIABETES CARE DEVICES MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 23. ASIA-PACIFIC DIABETES CARE DEVICES MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 24. JAPAN DIABETES CARE DEVICES MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 25. CHINA DIABETES CARE DEVICES MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 26. INDIA DIABETES CARE DEVICES MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 27. AUSTRALIA DIABETES CARE DEVICES MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 28. SOUTH KOREA DIABETES CARE DEVICES MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 29. REST OF ASIA-PACIFIC DIABETES CARE DEVICES MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 30. LAMEA DIABETES CARE DEVICES MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 31. LAMEA DIABETES CARE DEVICES MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 32. BRAZIL DIABETES CARE DEVICES MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 33. SOUTH AFRICA DIABETES CARE DEVICES MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 34. SAUDI ARABIA DIABETES CARE DEVICES MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 35. REST OF LAMEA DIABETES CARE DEVICES MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 36. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 37. ACON LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 38. ASCENSIA DIABETES CARE HOLDINGS AG: COMPANY SNAPSHOT
TABLE 39. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 40. DEXCOM, INC.: COMPANY SNAPSHOT
TABLE 41. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
TABLE 42. JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 43. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 44. NOVO NORDISK A/S: COMPANY SNAPSHOT
TABLE 45. TERUMO CORPORATION: COMPANY SNAPSHOT
LIST OF FIGURES
FIGURE 1. DIABETES CARE DEVICES MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 8. MARKET SHARE ANALYSIS, DIABETES CARE DEVICES MARKET, 2016
FIGURE 9. IMPACT ANALYSIS: DIABETES CARE DEVICES MARKET
FIGURE 10. TOTAL NUMBER OF CLINICAL TRIALS IN DIABETES CARE DEVICES MARKET
FIGURE 11. TESTING STRIPS MARKET, 2016-2023 ($MILLION)
FIGURE 12. SELF-MONITORING BLOOD GLUCOSE METERS MARKET, 2016-2023 ($MILLION)
FIGURE 13. LANCETS MARKET, 2016-2023 ($MILLION)
FIGURE 14. CONTINUOUS GLUCOSE MONITORS MARKET, 2016-2023 ($MILLION)
FIGURE 15. INSULIN SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 16. INSULIN PENS MARKET, 2016-2023 ($MILLION)
FIGURE 17. INSULIN PUMPS MARKET, 2016-2023 ($MILLION)
FIGURE 18. INSULIN JET INJECTORS MARKET, 2016-2023 ($MILLION)
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
